姓名：杜江鋒 性別：男 政治面貌：中共黨員 學(xué)歷：研究生學(xué)位：博士職稱：教授

博、碩導(dǎo)師：博導(dǎo) 本崗位工作年數(shù)：5

研究方向：

輻射增敏與輻射防護

抗炎性納米藥物

榮譽稱號：

2018年度“三晉英才”支持計劃青年優(yōu)秀人才

學(xué)術(shù)任職：

中國生物醫(yī)學(xué)工程學(xué)會醫(yī)學(xué)影像工程與技術(shù)分會青年委員，

第二屆中國研究型醫(yī)院學(xué)會精準(zhǔn)醫(yī)學(xué)與腫瘤MDT專業(yè)委員會常務(wù)委員

近五年承擔(dān)科研課題情況：

例如：中央引導(dǎo)地方科技發(fā)展資金項目（自由探索類基礎(chǔ)研究） 項目名稱：脊髓損傷后膀胱功能障礙的代謝組學(xué)研究，項目編號: YDZJSX2022A065

1.中國輻射防護研究院平臺開放課題重點項目，177Lu標(biāo)記負(fù)載ATR抑制劑的納米氧化鉿腫瘤內(nèi)放療免疫療效及機制研究，CIRP-CAEA20240201。

2.山西省基礎(chǔ)研究計劃（自由探索類），177Lu-HfO2@ATRi@Alg增敏肝癌內(nèi)放療免疫療效及機制研究，202303021221223。

3.山西省醫(yī)學(xué)重點科研項目，負(fù)載地西他濱的氧化鉿納米放療增敏劑協(xié)同增強腫瘤細胞焦亡與免疫治療研究，2023XM036。

4.國家自然科學(xué)基金委員會青年科學(xué)基金項目，生物可利用硒代半胱氨酸基納米放療增敏劑的構(gòu)建及其對肝癌的放療/熱療增敏研究，81901889。

5.山西省重點研發(fā)計劃（高新領(lǐng)域）一般項目，生物可利用硒代半胱氨酸基納米材料的構(gòu)建及其在抑制三陰性乳腺癌轉(zhuǎn)移和復(fù)發(fā)中的研究，201903D121110。

代表性論著及近五年的代表性論文（限10項以內(nèi)）：

(1)Yitong Yuan^#, Miaomiao Xu^#, Limin Feng^#, Wanting Zhong, Longzhu Zhang, Ruochen Du, Jingjing Sun*, Chunfang Wang*, Jiangfeng Du*, Nanozyme Hydrogels Promote Nerve Regeneration in Spinal Cord Injury by Reducing Oxidative Stress, ACS Applied Materials Interfaces, 2024, 16(44): 59949-59961. (IF=8.3) 2區(qū)

(2)Fang Liu^#, Kun Zhang^#, Bin Lu^#, Xiaochun Wang*, Qingrong Dong, Tingyu Xue, Yan Tan, Xing Wang*, Jiangfeng Du*, Oxygen-Vacancy-Rich Monolayer BiO_2-XNanosheets for Bacterial Sepsis Management via Dual Physically Antibacterial and Chemically Anti-inflammatory Functions, Advanced Healthcare Materials, 2024, 13(18): 2304002. (Inside Back Cover)(IF=10.0) 1區(qū)

(3)Bin Lu^#, Ling Wei^#, Gaoxiang Shi,Jiangfeng Du*. Nanotherapeutics for Alleviating Anesthesia-Associated Complications. Advanced Science, 2024, 11(15): 2308241. (IF=15.1) 1區(qū)

(4)Bin Zhao^#, Zhili Ma^#, Shuaishuai Ding, Yuhua Cao,Jiangfeng Du*, Lijuan Zeng, Yunping Hu, Jingrong Zhou, Xiao Zhang*, Xiu-wu Bian, Gan Tian*, Catalytic MnWO₄Nanorods for Chemodynamic Therapy Synergized Radiotherapy of Triple Negative Breast Cancer, Advanced Functional Materials, 2023, 33(47): 2306328. (Cover Picture) (IF₂₀₂₃=19.0) 1區(qū)

(5)Ruixue Liu, Ronghua Wang, Maoru Zhao, Xianyu Zhu, Yaping Liu, Xiaochen Wu, Shuanglong Du, Zhanjun Gu*,Jiangfeng Du*,Ultra-small Radiosensitizers Deliver Epigenetic Drugs to Induce Pyroptosis and Boost Triple-negative Breast Cancer Radiotherapy, Nano Today, 2023, 52: 101997.(IF₂₀₂₃=17.4) 1區(qū)

(6)Ruixue Liu^#, Chenyang Zhang^#, Xiaochen Wu, Chengyan Wang, Maoru Zhao, Chao Ji, Xinghua Dong, Ronghua Wang, Huanhuan Ma, Xiaochun Wang, Yan Tan,Jiangfeng Du*, Zhanjun Gu*, Hafnium Oxide Nanoparticles Coated ATR Inhibitor to Enhance the Radiotherapy and Potentiate Antitumor Immune Response,Chemical Engineering Journal, 2023, 461:142085. (IF₂₀₂₃=15.1) 1區(qū)

(7)Qingrong Dong^#, Tingyu Xue^#, Haili Yan, Fang Liu, Ruixue Liu, Kun Zhang, Yu Chong*,Jiangfeng Du*, Hui Zhang*, Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy, Journal of Nanobiotechnology, 2023, 21(1): 395. (IF₂₀₂₃=10.2) 1區(qū)

(8)Haili Yan^#, Long Gao^#, You Liao, Dongmei Wang, Duiping Feng, Jianguo Li,Jiangfeng Du*, Zhanjun Gu*, Hui Zhang*, Hexagonal NaxWO₃nanocrystals with reversible valence states for microwave thermal and chemodynamic combined cancer therapy, Chemical Engineering Journal, 2022, 446:136869. (IF₂₀₂₂=16.744) 1區(qū)

(9)Ruixue Liu^#, Linji Gong^#, Xianyu Zhu, Shuang Zhu, Xiaochen Wu, Tingyu Xue, Liang Yan,Jiangfeng Du*, Zhanjun Gu*, Transformable Gallium-based Liquid Metal Nanoparticles for Tumor Radiotherapy Sensitization,Advanced Healthcare Materials, 2022, 11(11):2102584. (IF₂₀₂₂=11.092) 1區(qū)

(10)Long Gao^#, Haili Yan^#, Shuang Zhu, Xiaochun Wang, Yan Tan,Jiangfeng Du*, Duiping Feng*, Hui Zhang*, Zhanjun Gu*, Targeted delivery of Bi₂Se₃Nanoflowers to orthotopic liver tumor via transarterial infusion for enhanced microwave ablation sensibilization, Nano Today, 2021, 41:101314. (IF₂₀₂₁=20.722) 1區(qū)